Clinical Study
Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma
Table 2
Adverse events at least possibly related to treatment.
| | Toxicity | Grade | | 1/2 | 3 | 4 | Total |
| | Headaches | 2 | 0 | 0 | 2 | | Fatigue | 2 | 0 | 0 | 2 | | Muscle pain | 1 | 0 | 0 | 1 | | Injection site reaction | 6 | 0 | 0 | 6 | | Induration | 1 | 0 | 0 | 1 | | Flushing | 1 | 0 | 0 | 1 | | Flu-like symptoms | 1 | 0 | 0 | 1 | | Pruritus | 1 | 0 | 0 | 1 | | Deep vein thrombosis | 0 | 1 | 0 | 1 | | Hyperbilirubinemia | 1 | 0 | 0 | 1 | | Elevated alkaline phosphatase | 1 | 0 | 0 | 1 | | Proteinuria | 1 | 0 | 0 | 1 |
| | Total | 18 | 1 | 0 | 19 |
|
|
